Free Trial

Vicarious Surgical (RBOT) Competitors

Vicarious Surgical logo
$6.90 -0.23 (-3.16%)
Closing price 03:58 PM Eastern
Extended Trading
$6.89 0.00 (-0.07%)
As of 05:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

RBOT vs. INGN, AVR, ZJYL, MLSS, NTRB, APT, SPAI, COCH, CLGN, and LFWD

Should you be buying Vicarious Surgical stock or one of its competitors? The main competitors of Vicarious Surgical include Inogen (INGN), Anteris Technologies Global (AVR), Jin Medical International (ZJYL), Milestone Scientific (MLSS), Nutriband (NTRB), Alpha Pro Tech (APT), Safe Pro Group Inc. Common Stock (SPAI), Envoy Medical (COCH), CollPlant Biotechnologies (CLGN), and ReWalk Robotics (LFWD). These companies are all part of the "surgical appliances & supplies" industry.

Vicarious Surgical vs.

Vicarious Surgical (NYSE:RBOT) and Inogen (NASDAQ:INGN) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, community ranking, institutional ownership, media sentiment, analyst recommendations, dividends, earnings and profitability.

Vicarious Surgical presently has a consensus price target of $9.25, suggesting a potential upside of 34.16%. Inogen has a consensus price target of $9.50, suggesting a potential upside of 40.74%. Given Inogen's stronger consensus rating and higher probable upside, analysts plainly believe Inogen is more favorable than Vicarious Surgical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Vicarious Surgical
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Inogen
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

Inogen received 382 more outperform votes than Vicarious Surgical when rated by MarketBeat users. Likewise, 68.78% of users gave Inogen an outperform vote while only 32.00% of users gave Vicarious Surgical an outperform vote.

CompanyUnderperformOutperform
Vicarious SurgicalOutperform Votes
8
32.00%
Underperform Votes
17
68.00%
InogenOutperform Votes
390
68.78%
Underperform Votes
177
31.22%

Vicarious Surgical has higher earnings, but lower revenue than Inogen. Inogen is trading at a lower price-to-earnings ratio than Vicarious Surgical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Vicarious SurgicalN/AN/A-$71.07M-$10.45-0.66
Inogen$339.96M0.53-$102.45M-$1.15-5.87

In the previous week, Inogen had 3 more articles in the media than Vicarious Surgical. MarketBeat recorded 6 mentions for Inogen and 3 mentions for Vicarious Surgical. Inogen's average media sentiment score of 0.96 beat Vicarious Surgical's score of -0.67 indicating that Inogen is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Vicarious Surgical
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Negative
Inogen
3 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

47.3% of Vicarious Surgical shares are held by institutional investors. Comparatively, 89.9% of Inogen shares are held by institutional investors. 12.0% of Vicarious Surgical shares are held by insiders. Comparatively, 1.5% of Inogen shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Vicarious Surgical has a beta of 1.46, suggesting that its stock price is 46% more volatile than the S&P 500. Comparatively, Inogen has a beta of 1.63, suggesting that its stock price is 63% more volatile than the S&P 500.

Vicarious Surgical has a net margin of 0.00% compared to Inogen's net margin of -15.89%. Inogen's return on equity of -27.38% beat Vicarious Surgical's return on equity.

Company Net Margins Return on Equity Return on Assets
Vicarious SurgicalN/A -81.46% -63.62%
Inogen -15.89%-27.38%-16.77%

Summary

Inogen beats Vicarious Surgical on 13 of the 17 factors compared between the two stocks.

Get Vicarious Surgical News Delivered to You Automatically

Sign up to receive the latest news and ratings for RBOT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RBOT vs. The Competition

MetricVicarious SurgicalSurgical appliances & supplies IndustryMedical SectorNYSE Exchange
Market Cap$40.89M$9.43B$5.33B$19.30B
Dividend YieldN/A1.62%5.21%3.84%
P/E Ratio-0.6720.7426.7134.53
Price / SalesN/A61.22386.1334.83
Price / CashN/A19.6738.2517.51
Price / Book0.415.096.774.69
Net Income-$71.07M$284.66M$3.23B$1.02B
7 Day Performance-3.16%-1.18%1.80%-1.74%
1 Month Performance29.75%1.44%11.10%7.50%
1 Year Performance-45.07%-21.91%17.11%4.15%

Vicarious Surgical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RBOT
Vicarious Surgical
2.1167 of 5 stars
$6.90
-3.2%
$9.25
+34.2%
-32.9%$40.89MN/A-0.673
INGN
Inogen
4.1349 of 5 stars
$6.13
+0.7%
$7.00
+14.2%
-30.8%$164.82M$339.96M-2.721,030Analyst Upgrade
Gap Up
AVR
Anteris Technologies Global
N/A$3.99
-3.9%
$16.50
+313.5%
N/A$143.89M$2.71M0.00138Gap Down
ZJYL
Jin Medical International
N/A$0.81
+1.2%
N/A-72.2%$126.24M$23.50M0.00245
MLSS
Milestone Scientific
1.1458 of 5 stars
$1.02
+14.0%
$1.25
+22.5%
+26.5%$79.95M$8.63M-14.5730
NTRB
Nutriband
2.1851 of 5 stars
$5.71
+1.6%
$13.00
+127.7%
+9.2%$62.69M$2.14M-8.0410
APT
Alpha Pro Tech
N/A$4.41
-1.1%
N/A-10.6%$48.45M$58.18M11.92120Gap Down
SPAI
Safe Pro Group Inc. Common Stock
N/A$2.98
+1.0%
N/AN/A$45.21M$2.17M-3.6811Earnings Report
Gap Down
COCH
Envoy Medical
1.743 of 5 stars
$1.70
+1.2%
$9.13
+436.8%
-47.5%$36.26M$212,000.00-1.2334Gap Down
CLGN
CollPlant Biotechnologies
2.5412 of 5 stars
$1.74
+0.6%
$12.50
+618.4%
-67.5%$19.93M$515,000.00-1.1370Upcoming Earnings
LFWD
ReWalk Robotics
2.8135 of 5 stars
$1.29
-0.8%
$9.00
+597.7%
-76.5%$13.71M$25.66M-0.5260Earnings Report

Related Companies and Tools


This page (NYSE:RBOT) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners